EPAS1 and hepatocellular carcinoma: This concept is further supported by either immuno-histochemistry analysis performed in a series of HCC specimens and by the analysis of SERPINB3 and HIF-2α transcript levels in HCC specimens obtained from a well characterized cohort of 67 HCC patients [30].